<?xml version="1.0" encoding="UTF-8"?>
<results title="binomial">
 <result pre=", staphylococci are predominant causes of biofilm-associated infections. Staphylococci, especially " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" ( S. aureus) is an extraordinarily versatile pathogen that can survive in hostile environme" name="binomial"/>
 <result pre=" causes of biofilm-associated infections. Staphylococci, especially Staphylococcus aureus ( " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=") is an extraordinarily versatile pathogen that can survive in hostile environmental conditions, co" name="binomial"/>
 <result pre="can cause severe, non-purulent, toxin-mediated diseases or invasive pyogenic infections in humans. " exact="Staphylococcus epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" ( S. epidermidis) has also emerged as an important opportunistic pathogen in infections ass" name="binomial"/>
 <result pre="n-mediated diseases or invasive pyogenic infections in humans. Staphylococcus epidermidis ( " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=") has also emerged as an important opportunistic pathogen in infections associated with medical dev" name="binomial"/>
 <result pre="fic community is continuously looking for new agents endowed of anti-biofilm capabilities to fight " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" and S epidermidis infections. Interestingly, several reports indicated in vitro efficacy of" name="binomial"/>
 <result pre="the objective of investigating their ability to modulate bacterial biofilm production of different " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" and S. epidermidis strains. Results showed the assayed EOs to modulated the biofilm product" name="binomial"/>
 <result pre="stigating their ability to modulate bacterial biofilm production of different S. aureus and " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" strains. Results showed the assayed EOs to modulated the biofilm production with unpredictable res" name="binomial"/>
 <result pre="results for each strain. In particular, many EOs acted mainly as biofilm inhibitors in the case of " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" strains, while for S. aureus strains, EOs induced either no effect or stimulate biofilm pro" name="binomial"/>
 <result pre="any EOs acted mainly as biofilm inhibitors in the case of S. epidermidis strains, while for " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" strains, EOs induced either no effect or stimulate biofilm production. In order to elucidate the o" name="binomial"/>
 <result pre="lent causes of biofilm-associated infections [ 6]. In particular, " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" ( S. aureus) is an opportunistic pathogen that can cause serious diseases in humans, rangin" name="binomial"/>
 <result pre="ed infections [ 6]. In particular, Staphylococcus aureus ( " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=") is an opportunistic pathogen that can cause serious diseases in humans, ranging from skin and sof" name="binomial"/>
 <result pre="ules-24-00890&quot;&gt;7]. In 2013, Nicholson et al. reported that 30% of U.S. population was colonized by " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" while 1.5% was found to be a carrier of methicillin-resistant S. aureus (MRSA), a major cau" name="binomial"/>
 <result pre="on was colonized by S. aureus while 1.5% was found to be a carrier of methicillin-resistant " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" (MRSA), a major cause of healthcare-related infections responsible for a significant proportion of" name="binomial"/>
 <result pre="ose from many other infectious diseases, including HIV/AIDS [ 8]. " exact="Staphylococcus epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" ( S. epidermidis), conventionally considered a commensal of human skin, can cause significa" name="binomial"/>
 <result pre="ses, including HIV/AIDS [ 8]. Staphylococcus epidermidis ( " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post="), conventionally considered a commensal of human skin, can cause significant problems when breachi" name="binomial"/>
 <result pre="9, 10]. Most diseases caused by " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" exhibit a chronic profile and occur as device-related infections (such as intravascular catheter o" name="binomial"/>
 <result pre="o the scientific community is seeking for new agents endowed of anti-biofilm capabilities to fight " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" and S epidermidis infections. Recently, several reports indicated in vitro efficacy of non-" name="binomial"/>
 <result pre="ferent applications, EOs have been found of some efficacy in reducing biofilm production of either " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" standard strains or MRSA [ 12, &lt;a href=&quot;#B13-molecules-24-00890&quot;" name="binomial"/>
 <result pre="een proved as a tool able to deeply investigate the modulatory role of EOs’ chemical components on " exact="Pseudomonas aeruginosa" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Pseudomonas aeruginosa" post=" biofilm production [ 21, 22, &lt;" name="binomial"/>
 <result pre=" plants were analyzed: 13 EOs (RSEOs) from Ridolfia segetum Moris (RS); 32 EOs (FVEOs) from " exact="Foeniculum vulgare" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Foeniculum vulgare" post=" Miller (FV) and 44 EOs (CGEOs) from Calamintha nepeta (L.) Savi subsp. glandulosa (R" name="binomial"/>
 <result pre=" Moris (RS); 32 EOs (FVEOs) from Foeniculum vulgare Miller (FV) and 44 EOs (CGEOs) from " exact="Calamintha nepeta" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Calamintha nepeta" post=" (L.) Savi subsp. glandulosa (Req.) Ball, (CG) [ 22]. In l" name="binomial"/>
 <result pre="n extensive study of the 89 EOs samples as potential antibacterial and anti-biofilm agents against " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" ATCC 6538P, S. aureus ATCC 25923, S. epidermidis RP62A and S. epidermidis O-4" name="binomial"/>
 <result pre="Os samples as potential antibacterial and anti-biofilm agents against S. aureus ATCC 6538P, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" ATCC 25923, S. epidermidis RP62A and S. epidermidis O-47. To this purpose, like prev" name="binomial"/>
 <result pre="acterial and anti-biofilm agents against S. aureus ATCC 6538P, S. aureus ATCC 25923, " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" RP62A and S. epidermidis O-47. To this purpose, like previously reported [ &lt;a href=&quot;#B22-mo" name="binomial"/>
 <result pre=" against S. aureus ATCC 6538P, S. aureus ATCC 25923, S. epidermidis RP62A and " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" O-47. To this purpose, like previously reported [ 22], ML algori" name="binomial"/>
 <result pre="-24-00890-t003&quot;&gt;Table 3). Only seven out 89 EOs displayed MIC values of 6.25 mg/mL against the two " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" strains ( Table 1, Table 2 a" name="binomial"/>
 <result pre="minarily, the same representative EOs (2 RSEOs, 3 CGEOs and 3 FVEOs) among the reported 89 used on " exact="P. aeruginosa" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Pseudomonas aeruginosa" post=" [ 22] were selected, to evaluate the anti-biofilm potency at dif" name="binomial"/>
 <result pre=" ≥120%, ≥150% and ≥200%, respectively) biofilm formation is reported. It is worthy to note that on " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" strains about 30 EOs inhibited more than 50% of biofilm growth even at lowest concentration, while" name="binomial"/>
 <result pre="0% of biofilm growth even at lowest concentration, while almost none of them showed an activity on " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" strains. " name="binomial"/>
 <result pre="re than 70% of biofilm formation were further analyzed to evaluate a dose-dependent effect against " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" RP62A and O-47 ( Figure 4, F" name="binomial"/>
 <result pre="vealed a dose dependent biofilm inhibition being more pronounced on the strongest biofilm producer " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" O-47 than on S. epidermidis RP62A ( Figure 6). " name="binomial"/>
 <result pre="ibition being more pronounced on the strongest biofilm producer S. epidermidis O-47 than on " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" RP62A ( Figure 6). " name="binomial"/>
 <result pre="Analogously as in ML application to " exact="Pseudomonas aeruginosa" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Pseudomonas aeruginosa" post=" (PA) [ 22] direct application of linear classification methods u" name="binomial"/>
 <result pre="mation, likely depending on its characteristics and unique chemical composition. In particular for " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" strains 6538P and 25923 the EOs mainly exhibited an enhancement of biofilm production. Stimulation" name="binomial"/>
 <result pre="and more common [ 32, 33], for " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" strains RP62A and O-47 an overall inhibition effect on biofilm production was observed by in vitro" name="binomial"/>
 <result pre="itro EOs treatment. Nevertheless, cinnamon EO was reported to stimulate biofilm production on some " exact="Staphylococcus epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" strains [ 34]. " name="binomial"/>
 <result pre="The majority of tested RSEO samples did not show inhibitory effects on " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" 6538P biofilm formation (a partial inhibitory effect was observed only for R6 essential oil at 3.1" name="binomial"/>
 <result pre="by up to 140% at 0.0488 mg/mL Differently, several RSEO samples showed a good inhibitory effect on " exact="S. epidermids" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermids" post=" RP62A biofilm production. In particular 4 out of 13 EOs (R6, R24, RM4 and RM6) were able to potent" name="binomial"/>
 <result pre="by about 50% at 3.125 mg/mL. On the contrary, some FVEOs proved to be potent antibiofilm agents on " exact="S. epidermids" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermids" post=" RP62A (panel B of Figure 2). In particular 5 out 33 FVEOs (FO1," name="binomial"/>
 <result pre=" formation of about 50–70% (panel C of Figure 2). While on both " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" strains RP62A and O-47, FVEOs displayed some peculiar samples with interesting biofilm inhibitory " name="binomial"/>
 <result pre="anktonic cultures were grown in flasks under vigorous agitation (180 rpm) at 37 °C. In particular, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" ATCC 6538P (6538P) and S. aureus ATCC 25923 (25923) are reference strains for antimicrobial" name="binomial"/>
 <result pre="nder vigorous agitation (180 rpm) at 37 °C. In particular, S. aureus ATCC 6538P (6538P) and " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" ATCC 25923 (25923) are reference strains for antimicrobial testing; S. epidermidis RP62A (R" name="binomial"/>
 <result pre="P (6538P) and S. aureus ATCC 25923 (25923) are reference strains for antimicrobial testing; " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" RP62A (RP62A) is a reference strain isolated from infected catheter, while S. epidermidis O" name="binomial"/>
 <result pre="; S. epidermidis RP62A (RP62A) is a reference strain isolated from infected catheter, while " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" O-47 (O-47) is a clinical isolate strong biofilm producer strain characterized by a genomic mutati" name="binomial"/>
 <result pre=" treatment at two concentrations (3.125 mg/mL and 0.0488 mg/mL) for RSEOs against the four strains " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" 6538P ( A) and 25923 ( B), S. epidermidis RP62A ( C) and O-47 ( D, respectively). In the or" name="binomial"/>
 <result pre="L and 0.0488 mg/mL) for RSEOs against the four strains S. aureus 6538P ( A) and 25923 ( B), " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" RP62A ( C) and O-47 ( D, respectively). In the ordinate axis are reported the percentage of bacter" name="binomial"/>
 <result pre=" treatment at two concentrations (3.125 mg/mL and 0.0488 mg/mL) for FVEOs against the four strains " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" 6538P ( A) and 25923 ( B), S. epidermidis RP62A ( C) and O-47 ( D, respectively). In the or" name="binomial"/>
 <result pre="L and 0.0488 mg/mL) for FVEOs against the four strains S. aureus 6538P ( A) and 25923 ( B), " exact="S. epidermidis" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus epidermidis" post=" RP62A ( C) and O-47 ( D, respectively). In the ordinate axis are is reported the percentage of bac" name="binomial"/>
 <result pre=" treatment at two concentrations (3.125 mg/mL and 0.0488 mg/mL) for CGEOs against the four strains " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[3]/p[1]" match="Staphylococcus aureus" post=" 6538P ( A) and 25923 ( B), S. epidermidis RP62A ( C) and O-47 ( D), respectively). In the o" name="binomial"/>
 <result pre="L and 0.0488 mg/mL) for CGEOs against the four strains S. aureus 6538P ( A) and 25923 ( B), " exact="S. epidermidis" match="Staphylococcus epidermidis" post=" RP62A ( C) and O-47 ( D), respectively). In the ordinate axis are is reported the percentage of ba" name="binomial"/>
</results>
